Randomized, Controlled, Blinded, Pilot Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients

Trial Profile

Randomized, Controlled, Blinded, Pilot Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients

Completed
Phase of Trial: Phase I/II

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs Omalizumab (Primary)
  • Indications Food hypersensitivity
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 11 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top